A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.
复制标题

对患有儿童期注意力缺陷多动障碍的成年人进行哌醋甲酯和安慰剂的双盲交叉比较。

DOI:
--
复制
发表时间:
1995
影响因子:
--
通讯作者:
K. A. Lapey
K. A. Lapey
中科院分区:
--
文献类型:
--
作者:
T. Spencer;T. Wilens;J. Biederman;S. Faraone;J. Ablon;K. A. Lapey

文献摘要

参考文献

被引文献

相似文献

背景 盐酸哌甲酯用于治疗注意力缺陷多动障碍 (ADHD) 成人的对照研究很少,而且其结果也模棱两可。这些研究之间的差异可能与低剂量、诊断不确定性和缺乏对共病的关注有关。 方法 我们对 23 名患有 DSM-III-R ADHD 的成年患者进行了一项随机、为期 7 周、安慰剂对照、交叉研究,使用标准化诊断仪器、单独评估 ADHD 以及抑郁和焦虑症状,以及盐酸哌甲酯的每日剂量(1.0 mg/kg)。 结果 我们发现哌醋甲酯治疗 ADHD 症状的显着治疗反应超过了安慰剂反应(78% vs 4%,P < .0001)。对哌醋甲酯的反应与性别、伴有焦虑或中度抑郁的精神合并症或精神疾病家族史无关。 结论 大剂量的哌醋甲酯可有效治疗成人多动症。
BACKGROUND There are few controlled studies of methylphenidate hydrochloride in adults with attention-deficit hyperactivity disorder (ADHD), and their results have been equivocal. The discrepancies among these studies may be related to low doses, diagnostic uncertainties, and lack of attention to comorbid disorders. METHODS We conducted a randomized, 7-week, placebo-controlled, crossover study of methylphenidate in 23 adult patients with DSM-III-R ADHD using standardized instruments for diagnosis, separate assessments of ADHD and depressive and anxiety symptoms, and a robust daily dose of methylphenidate hydrochloride, 1.0 mg/kg per day. RESULTS We found a marked therapeutic response for methylphenidate treatment of ADHD symptoms that exceeded the placebo response (78% vs 4%, P < .0001). Response to methylphenidate was independent of gender, psychiatric comorbidity with anxiety or moderate depression, or family history of psychiatric disorders. CONCLUSION Robust doses of methylphenidate are effective in the treatment of adult ADHD.
DOI: 10.1001/archpsyc.1992.01820090056010
发表时间: 1992-09
影响因子: --
作者:
J. Biederman;S. Faraone;K. Keenan;J. Benjamin;B. Krifcher;Cynthia Moore;S. Sprich-Buckminster;
通讯作者: J. Biederman;S. Faraone;K. Keenan;J. Benjamin;B. Krifcher;Cynthia Moore;S. Sprich-Buckminster;
DOI: 10.1097/00004583-199003000-00006
发表时间: 1990
影响因子: 13.3
作者:
Deutsch,CK;Matthysse,S;Swanson,JM;Farkas,LG
通讯作者: Farkas,LG
DOI: 10.1001/archpsyc.1990.01810130023004
发表时间: 1990
影响因子: --
作者:
Biederman,J;Rosenbaum,JF;Hirshfeld,DR;Faraone,SV;Bolduc,EA;Gersten,M;Meminger,SR;Kagan,J;Snidman,N;Reznick,JS
通讯作者: Reznick,JS
DOI: 10.1001/archpsyc.1991.01810250079012
发表时间: 1991
影响因子: --
作者:
Mannuzza,S;Klein,RG;Bonagura,N;Malloy,P;Giampino,TL;Addalli,KA
通讯作者: Addalli,KA
成人注意力缺陷障碍。
DOI: 10.1097/00002826-198512000-00005
发表时间: 1985
影响因子: 1
作者:
Gualtieri,CT;Ondrusek,MG;Finley,C
通讯作者: Finley,C